A new FGF21 analog for the treatment of fatty liver disease

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Standard

A new FGF21 analog for the treatment of fatty liver disease. / Kleinert, Maximilian; Müller, Timo D.

I: Diabetes, Bind 69, Nr. 8, 2020, s. 1605-1607.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Harvard

Kleinert, M & Müller, TD 2020, 'A new FGF21 analog for the treatment of fatty liver disease', Diabetes, bind 69, nr. 8, s. 1605-1607. https://doi.org/10.2337/dbi20-0025

APA

Kleinert, M., & Müller, T. D. (2020). A new FGF21 analog for the treatment of fatty liver disease. Diabetes, 69(8), 1605-1607. https://doi.org/10.2337/dbi20-0025

Vancouver

Kleinert M, Müller TD. A new FGF21 analog for the treatment of fatty liver disease. Diabetes. 2020;69(8):1605-1607. https://doi.org/10.2337/dbi20-0025

Author

Kleinert, Maximilian ; Müller, Timo D. / A new FGF21 analog for the treatment of fatty liver disease. I: Diabetes. 2020 ; Bind 69, Nr. 8. s. 1605-1607.

Bibtex

@article{8ae3c6e3039b4506b20e02cfcb79d3de,
title = "A new FGF21 analog for the treatment of fatty liver disease",
keywords = "Faculty of Science, Fibroblast Growtf Factor 21, FGF21, Fatty liver disease, Treatment, Animal studies",
author = "Maximilian Kleinert and M{\"u}ller, {Timo D}",
note = "CURIS 2020 NEXS 249",
year = "2020",
doi = "10.2337/dbi20-0025",
language = "English",
volume = "69",
pages = "1605--1607",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association",
number = "8",

}

RIS

TY - JOUR

T1 - A new FGF21 analog for the treatment of fatty liver disease

AU - Kleinert, Maximilian

AU - Müller, Timo D

N1 - CURIS 2020 NEXS 249

PY - 2020

Y1 - 2020

KW - Faculty of Science

KW - Fibroblast Growtf Factor 21

KW - FGF21

KW - Fatty liver disease

KW - Treatment

KW - Animal studies

UR - http://www.scopus.com/inward/record.url?scp=85088351836&partnerID=8YFLogxK

U2 - 10.2337/dbi20-0025

DO - 10.2337/dbi20-0025

M3 - Comment/debate

C2 - 32690662

AN - SCOPUS:85088351836

VL - 69

SP - 1605

EP - 1607

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -

ID: 246350644